title: Effects of in vivo prematuration and in vivo final maturation on developmental capacity and quality of pre-implantation embryos.
abstract: In current in vitro production (IVP) systems, oocytes lack in vivo dominant and preovulatory follicular development, which may compromise pregnancy and viability of calves born. When an oocyte sets off in vivo on the road toward fertilization, it contains numerous transcripts and proteins necessary to survive the first few cell cycles of embryonic development. It is not yet known during which period of development the oocyte builds up the store, possibly primarily during the major growth phase of the oocyte, which is completed at the time a follicle reaches the size of 3 mm. Here, we investigated to what extent the later phases of follicular development, such as prematuration in the dominant follicle before the LH surge and ensuing final maturation in the preovulatory follicle, contribute to oocyte competence and development into viable biastocysts. Recent studies on in vivo vs in vitro oocyte maturation employed oocytes from an identical preovulatory development by applying ovum pick-up (OPU) twice (before and 24 h after the LH surge) in each cow treated for superovulation with a controlled LH surge. The embryo recovery rates at Day 7 of IVC after IVF were similar: 44% (97/219) for in vivo- vs 41% (87/213) for in vitro-matured oocytes, which shows that the natural environment during final maturation is not essential for the mere in vitro development of the prematured oocyte beyond the 8- to 16-cell stage. However, in vivo maturation appeared to contribute to the oocyte's quality in a more subtle way, as indicated by a significant increase in the proportion of expanded blastocysts and a more physiological degree of chromosome aberrations of the embryos. In blastocysts derived from in vivo-matured oocytes, 21% of the embryos were mixoploid vs 50% from in vitro-matured oocytes, concomitant with a higher number of cells (96 vs 54 per normal blastocyst). The expression pattern of a set of six developmentally important genes was, however, not significantly altered in blastocysts derived from in vivo-matured oocytes. Certain deviations were observed compared with the levels of entirely in vivo-developed control blastocysts, which suggests that the beneficial effects of in vivo maturation are possibly exerted at initial stages of embryonic development. Prematuration in vivo, occurring in a dominant follicle developing from about 8 mm into the preovulatory follicle, is accompanied by changes in protein synthesis of the cumulus oocyte complex (COC). Presumably, the differentially expressed proteins are involved in equipping the oocyte with further developmental competence. Although we have unraveled some important biochemical and cellular biological features of the oocyte, further research on in vivo processes is essential to improve in vitro embryo production in practice.
authors.affiliation: Department of Farm Animal Health, Faculty of Veterinary Medicine, Utrecht University, The Netherlands.
authors.forename: S J
authors.initials: SJ
authors.lastname: Dieleman
authors.forename: P J M
authors.initials: PJ
authors.lastname: Hendriksen
authors.forename: D
authors.initials: D
authors.lastname: Viuff
authors.forename: P D
authors.initials: PD
authors.lastname: Thomsen
authors.forename: P
authors.initials: P
authors.lastname: Hyttel
authors.forename: H M
authors.initials: HM
authors.lastname: Knijn
authors.forename: C
authors.initials: C
authors.lastname: Wrenzycki
authors.forename: T A M
authors.initials: TA
authors.lastname: Kruip
authors.forename: H
authors.initials: H
authors.lastname: Niemann
authors.forename: B M
authors.initials: BM
authors.lastname: Gadella
authors.forename: M M
authors.initials: MM
authors.lastname: Bevers
authors.forename: P L A M
authors.initials: PL
authors.lastname: Vos
mesh_terms: D000818:Animals; D001755:Blastocyst / Q000166:cytology*; D002417:Cattle / Q000196:embryology* / Q000502:physiology; D002453:Cell Cycle; D002478:Cells, Cultured; D004622:Embryo, Mammalian / Q000166:cytology*; D005314:Embryonic and Fetal Development; D005260:Female; D066298:In Vitro Techniques; D007986:Luteinizing Hormone / Q000378:metabolism / Q000494:pharmacology; D009865:Oocytes / Q000166:cytology*; D006080:Ovarian Follicle / Q000166:cytology / Q000502:physiology; D013480:Superovulation
chemical_list: D007986:Luteinizing Hormone